Home › Companies › PUMA BIOTECHNOLOGY INC. › 2024-2025
Compiled from SEC Form N-PX filings and PUMA BIOTECHNOLOGY INC.’s Form 8-K, filed 2025-06-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore PUMA BIOTECHNOLOGY INC. in the interactive database Compare manager voting policies
These tallies are PUMA BIOTECHNOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Alan H. Auerbach | 34,639,223 | -- | -- | 408,312 | 6,521,146 | Majority: yes |
| Elect Director: Alessandra Cesano | 26,100,362 | -- | -- | 8,947,173 | 6,521,146 | Majority: yes |
| Elect Director: Allison Dorval | 34,757,965 | -- | -- | 289,570 | 6,521,146 | Majority: yes |
| Elect Director: Michael P. Miller | 34,501,336 | -- | -- | 546,199 | 6,521,146 | Majority: yes |
| Elect Director: Jay M. Moyes | 34,453,681 | -- | -- | 593,854 | 6,521,146 | Majority: yes |
| Elect Director: Adrian M. Senderowicz | 34,504,501 | -- | -- | 543,034 | 6,521,146 | Majority: yes |
| Elect Director: Brian Stuglik | 34,742,184 | -- | -- | 305,351 | 6,521,146 | Majority: yes |
| Elect Director: Troy E. Wilson | 24,308,330 | -- | -- | 10,739,205 | 6,521,146 | Majority: yes |
| Proposal 2: The Company's stockholders ratified the selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025. | 40,683,257 | 739,693 | 145,731 | -- | 0 | Majority: yes |
| Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers. | 32,617,895 | 1,698,665 | 730,975 | -- | 6,521,146 | Majority: yes |
Source: PUMA BIOTECHNOLOGY INC., Form 8-K, filed with the SEC on 2025-06-13 — read the filing on EDGAR.
Each item below shows how the 146 asset managers that disclosed a PUMA BIOTECHNOLOGY INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers.”): 32,617,895 for, 1,698,665 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 66% for, 3% against (69% of the company cast a for/against vote).
The 146 asset managers below cast 95% of the shares they voted on this item FOR (20,525,806 for, 1,040,723 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,767,324 | 0 | 0 | 0 | For |
| BlackRock | 3,305,636 | 0 | 0 | 0 | For |
| American Century | 2,375,871 | 0 | 0 | 0 | For |
| Fidelity | 1,187,570 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 967,097 | 0 | 0 | 0 | For |
| Renaissance | 810,228 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 638,594 | 96,405 | 0 | 0 | For |
| SEI | 665,235 | 0 | 0 | 0 | For |
| State Street | 605,267 | 2,376 | 0 | 0 | For |
| Dimensional | 0 | 517,234 | 0 | 0 | Against |
| DE Shaw | 513,242 | 0 | 0 | 0 | For |
| Federated Hermes | 392,585 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 390,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 289,835 | 7,140 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 295,497 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 275,788 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 275,565 | 0 | 0 | 0 | For |
| Charles Schwab | 254,631 | 0 | 0 | 0 | For |
| Northern Trust | 232,231 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 224,133 | 0 | 0 | 0 | For |
| Two Sigma | 222,285 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 160,800 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 157,713 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 143,386 | 7,436 | 0 | 0 | For |
Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.
98% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Proposal 2: The Company's stockholders ratified the selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025.”): 40,683,257 for, 739,693 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 82% for, 1% against (83% of the company cast a for/against vote).
The 56 asset managers below cast 98% of the shares they voted on this item FOR (10,046,149 for, 179,549 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 141,300 | 0 | 0 | Against |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 34,023 | 0 | 0 | Against |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Adrian M. Senderowicz”): 34,504,501 for, 543,034 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 70% for, 1% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (10,112,240 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 0 | 0 | 71,800 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 0 | 34,023 | 0 | Abstain |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 34,639,223 for, 408,312 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 70% for, 0.9% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (10,218,063 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 26,100,362 for, 8,947,173 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 52.6% for, 18% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (3,803,989 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 86,986 | 0 | 3,635,534 | 0 | Abstain |
| BlackRock | 0 | 0 | 1,813,759 | 0 | Abstain |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 328,839 | 0 | Abstain |
| TARGET PORTFOLIO TRUST | 0 | 0 | 276,200 | 0 | Abstain |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 127,312 | 0 | Abstain |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 6,480 | 0 | 75,153 | 0 | Abstain |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 67,080 | 0 | Abstain |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 15,714 | 0 | 20,134 | 0 | Abstain |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Allison Dorval”): 34,757,965 for, 289,570 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 70% for, 0.6% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (10,222,289 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Brian Stuglik”): 34,742,184 for, 305,351 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 70% for, 0.7% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (10,222,118 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Jay M. Moyes”): 34,453,681 for, 593,854 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 69% for, 1% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (10,222,118 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Michael P. Miller”): 34,501,336 for, 546,199 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 70% for, 1% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (10,112,240 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 0 | 0 | 71,800 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 0 | 34,023 | 0 | Abstain |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
69% Majority: yes · of votes cast
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Troy E. Wilson”): 24,308,330 for, 10,739,205 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,638,093 outstanding shares: 49.0% for, 22% withheld (71% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (3,359,977 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 86,986 | 0 | 3,635,534 | 0 | Abstain |
| BlackRock | 0 | 0 | 1,813,759 | 0 | Abstain |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 328,839 | 0 | Abstain |
| TARGET PORTFOLIO TRUST | 0 | 0 | 276,200 | 0 | Abstain |
| Federated Hermes | 0 | 0 | 193,766 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 127,312 | 0 | Abstain |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 81,633 | 0 | Abstain |
| RBC FUNDS TRUST | 0 | 0 | 71,800 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 67,080 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 61,255 | 0 | Abstain |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 15,714 | 0 | 20,134 | 0 | Abstain |
| EA Series Trust | 0 | 0 | 34,023 | 0 | Abstain |
| Lincoln Financial | 3,378 | 0 | 29,500 | 0 | Abstain |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Ranked by the number of PUMA BIOTECHNOLOGY INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 49,638,093 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.59% |
| 2 | BlackRock | 6.66% |
| 3 | American Century | 4.79% |
| 4 | Fidelity | 2.39% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.95% |
| 6 | Renaissance | 1.63% |
| 7 | KENNEDY CAPITAL MANAGEMENT LLC | 1.48% |
| 8 | SEI | 1.34% |
| 9 | State Street | 1.22% |
| 10 | Dimensional | 1.04% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Anders Hove | 7.94% | 13G |
| BlackRock | 7.75% | 13F |
| Vanguard Group | 7.39% | 13F |
| Renaissance Technologies | 3.69% | 13F |
| Millennium Management | 2.79% | 13F |
| Geode Capital | 1.92% | 13F |
| Dimensional Fund Advisors | 1.79% | 13F |
| State Street | 1.31% | 13F |
| D.E. Shaw | 1.15% | 13F |
| BNY Mellon | 0.69% | 13F |
Percentages above are of 49,638,093 shares outstanding, as reported by PUMA BIOTECHNOLOGY INC. on its Form 10-Q dated 2025-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PUMA BIOTECHNOLOGY INC.’s 10-Q dated 2025-05-05. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At PUMA BIOTECHNOLOGY INC.'s shareholder meeting held 2025-06-11, in the 2024-2025 proxy season, 146 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 1,532 separate fund positions. On the most widely held item on that ballot — ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PUMA BIOTECHNOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-13.
PUMA BIOTECHNOLOGY INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.